326 filings
Page 5 of 17
8-K
3ee8geths3wt89
5 Apr 21
Departure of Directors or Certain Officers
4:50pm
8-K
cp1zb0js1m
22 Mar 21
Departure of Directors or Certain Officers
9:21am
8-K
n3plhy92br1efx2n93x
15 Mar 21
Completion of Acquisition or Disposition of Assets
4:23pm
8-K
zedrdxe9csfi78w rb
3 Mar 21
Departure of Directors or Certain Officers
4:07pm
S-8
1yred5fl1xg5h5y0t
22 Feb 21
Registration of securities for employees
4:27pm
8-K
r9at 6lz9idtk8io
17 Feb 21
Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results
4:17pm
424B5
nmsvr5oxg4 3iofqmrf
5 Feb 21
Prospectus supplement for primary offering
4:31pm
8-K
qd8wm7a
5 Feb 21
Veracyte Announces Pricing of Upsized Public Offering
6:17am
425
fp7asyqd 1s
3 Feb 21
Business combination disclosure
5:27pm
425
nc8598dxyztd
3 Feb 21
Business combination disclosure
5:07pm
425
amdhz0vaxcbfyo2
3 Feb 21
Business combination disclosure
5:03pm
425
y724y tdyd63lp
3 Feb 21
Business combination disclosure
5:02pm
424B5
ibcnjg
3 Feb 21
Prospectus supplement for primary offering
4:25pm
S-3ASR
blcfoxpxpz29t207u3
3 Feb 21
Automatic shelf registration
4:05pm
425
hzdbt7rt pmuxsr
3 Feb 21
Business combination disclosure
8:27am
8-K
m460n9880sfe3yy
3 Feb 21
Veracyte To Acquire Decipher Biosciences
8:21am
8-K
tp783f7k khhxkonm
25 Jan 21
Amendments to Articles of Incorporation or Bylaws
8:33am
8-K
jqxwnu5mylh
16 Dec 20
Veracyte Announces New Preliminary Data for Its In-Development
5:14pm
8-K
hq13wohkv ry4
17 Nov 20
Veracyte Announces New General Manager Structure to Advance Global Expansion
4:39pm